A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

NCT05775575 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: TQB3909 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.